Status:
COMPLETED
Bevacizumab for Central Retinal Vein Occlusion Study
Lead Sponsor:
Anders Kvanta
Conditions:
Central Retinal Vein Occlusion
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Central retinal vein occlusion is a leading cause of severe visual impairment. Until now, no treatment has been available to improve visual acuity. The present study intends to investigate if intravit...
Eligibility Criteria
Inclusion
- CRVO with duration \< 6 months
- Visual acuity of 20/800 to 20/50
Exclusion
- CRVO with duration of \> 6 months
- previous treatment with anti-angiogenic drugs
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00906685
Start Date
May 1 2009
End Date
September 1 2011
Last Update
November 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Eriks Eye Hospital
Stockholm, Sweden, 11282